首页> 外文期刊>Clinics >Expression of tumor suppressors miR-195 and let-7a as potential biomarkers of invasive breast cancer
【24h】

Expression of tumor suppressors miR-195 and let-7a as potential biomarkers of invasive breast cancer

机译:抑癌基因miR-195和let-7a表达作为浸润性乳腺癌的潜在生物标志物

获取原文
获取外文期刊封面目录资料

摘要

OBJECTIVE: MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression at the posttranscriptional level. Some miRNAs, including let-7a and miR-195, have been described as tumor suppressors. However, the roles of these microRNAs in breast cancer progression remain controversial. The aim of this study is to evaluate miR-195 and let-7a expression as potential biomarkers of invasive breast cancer. METHODS: In the present study, 200 individuals were separated into three groups: (i) 72 women constituting the control group who were selected according to rigorous and well-established criteria; (ii) 56 patients with benign breast tumors; and (iii) 72 patients with malignant breast cancers of different clinical stages. The miR-195 and let-7a expression levels in serum were evaluated by real-time PCR. The results were assessed alone and in combination, and the analysis included an estimation of sensitivity and specificity in ROC curves. RESULTS: Compared with the benign and control groups, both microRNAs were downregulated in the malignant breast cancer patient group. Compared with the malignant group, the combination of both biomarkers in the control and benign groups showed good sensitivity and specificity in the serum with AUCs of 0.75 and 0.72, respectively. The biomarker combination for the control group versus the malignant group exhibited a better sensitivity and specificity than for the benign group versus the malignant group. CONCLUSION: These findings support the evidence that the analysis of miR-195 and let-7a can be used as a non-invasive biomarker for breast cancer detection.
机译:目的:微小RNA(miRNA)是小的非编码RNA,可在转录后水平调节基因表达。一些miRNA,包括let-7a和miR-195,已被描述为肿瘤抑制因子。然而,这些微小RNA在乳腺癌进展中的作用仍存在争议。这项研究的目的是评估miR-195和let-7a表达作为浸润性乳腺癌的潜在生物标志物。方法:在本研究中,将200人分为三组:(i)根据严格和公认的标准选出的72名对照组妇女; (ii)56名乳腺良性肿瘤患者; (iii)72名不同临床阶段的恶性乳腺癌患者。通过实时PCR评估血清中的miR-195和let-7a表达水平。单独或组合评估结果,分析包括对ROC曲线的敏感性和特异性的评估。结果:与良性和对照组相比,在恶性乳腺癌患者组中两种microRNA均下调。与恶性组相比,对照组和良性组中两种生物标志物的组合在血清中均具有良好的敏感性和特异性,AUC分别为0.75和0.72。对照组与恶性组的生物标志物组合显示出比良性组与恶性组更好的敏感性和特异性。结论:这些发现支持了miR-195和let-7a的分析可以用作乳腺癌检测的非侵入性生物标志物的证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号